Movement Error-processes and Sensorimotor Adaptation in Parkinsonian Patient
Kinarm
2 other identifiers
observational
100
1 country
1
Brief Summary
The aim of the present project is to document the relationship between the behavioral deficits and the electrophysiological anomalies observed in PD patients in tasks involving motor adaptation to visual or mechanical perturbations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2017
CompletedFirst Posted
Study publicly available on registry
December 13, 2017
CompletedStudy Start
First participant enrolled
July 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
January 5, 2024
January 1, 2024
8.2 years
May 31, 2017
January 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The electrophysiological (EEG) activity by the BioSemi 64 electrodes system
Hertz identification of electrodes where signal fluctuations are the most important.
6 months
Study Arms (3)
Parkinsonian patient under dopaminergic medication
Parkinsonian patient without dopaminergic medication
Control participants
Interventions
Assessment of behavioral performance and the electrophysiological (EEG) activity in PD patients during the early and more advanced stages of the pathology, using an instrumentation, called the Kinarm, which assess objectively sensory, motor and cognitive functions
Eligibility Criteria
Patients suffering from Parkinson disease
You may qualify if:
- Patient aged over 18 years
- Right-handed patients , following the Modified Edinburgh Handedness Inventory
- Patient with Parkinson's disease according to Gibb criteria
- Idiopathic Parkinson's Disease with a history of more than 5 years
- Stimulation electrodes implanted in the 2 subthalamic nuclei in the Functional and Stereotactic Neurosurgery Department of La Timone Hospital (Pr REGIS).
- Dopa-sensitivity greater than 50%
- Absence of signs of cognitive impairment
- Patient who agreed to participate in the study and signed informed consent
- Patient affiliated with a health insurance
You may not qualify if:
- Person not likely to participate in the entire study
- Pregnant or likely to be pregnant during the year
- Patients unable to give their informed consent (detainees, adults under guardianship)
- Person unable to understand the nature and purpose of the study, or presneting with understanding difficulties which could compromise the proper conduct of the study
- Person refusing to sign the Informed Consent Form
- A person who is able to give his or her consent but unable to read / write French language
- patient who can not participate in an MRI study according to the criteria listed in the attached form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Neurologie, Hôpital de la Timone, Assistance Publique Hôpitaux de Marseille
Marseille, 13005, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Urielle DESALBRES
Assistance Publique Hôpitaux de Marseille
Central Study Contacts
Camille DELANNOY
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2017
First Posted
December 13, 2017
Study Start
July 4, 2019
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
January 5, 2024
Record last verified: 2024-01